Annual SGA
$3.55 M
NaN%
December 1, 2023
Summary
- As of February 9, 2025, CVKD annual SGA is $3.55 million
- CVKD annual SGA is now at all-time high.
Performance
CVKD SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.67 M
+$462.50 K+38.15%
September 1, 2024
Summary
- As of February 9, 2025, CVKD quarterly SGA is $1.67 million, with the most recent change of +$462.50 thousand (+38.15%) on September 1, 2024.
- Over the past year, CVKD quarterly SGA has stayed the same.
- CVKD quarterly SGA is now at all-time high.
Performance
CVKD Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$72.47 M
-$7.61 M-11.73%
September 1, 2024
Summary
- As of February 9, 2025, CVKD TTM SGA is -$72.47 million, with the most recent change of -$7.61 million (-11.73%) on September 1, 2024.
- Over the past year, CVKD TTM SGA has dropped by -$77.38 million (-1574.33%).
- CVKD TTM SGA is now -10576.09% below its all-time high of -$678.80 thousand.
Performance
CVKD TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CVKD Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | 0.0% | -1574.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CVKD Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +996.9% | <-9999.0% | at low |
| 5 y | 5-year | at high | at low | at high | +996.9% | <-9999.0% | at low |
| alltime | all time | at high | at low | at high | +996.9% | <-9999.0% | at low |
Cadrenal Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.67 M(+38.1%) | $4.92 M(+18.8%) |
| Jun 2024 | - | $1.21 M(+7.7%) | $4.14 M(+11.5%) |
| Mar 2024 | - | $1.13 M(+24.8%) | $3.71 M(+4.5%) |
| Dec 2023 | $3.55 M | $902.10 K(+0.4%) | $3.55 M(+34.1%) |
| Sep 2023 | - | $898.10 K(+14.5%) | $2.65 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $784.60 K(-18.7%) | $2.67 M(+23.3%) |
| Mar 2023 | - | $964.70 K(+5.3%) | $2.16 M(+60.2%) |
| Sep 2022 | - | $915.90 K(+227.0%) | $1.35 M(+211.6%) |
| Jun 2022 | - | $280.10 K(+83.4%) | $432.80 K(+183.4%) |
| Mar 2022 | - | $152.70 K | $152.70 K |
FAQ
- What is Cadrenal Therapeutics annual SGA?
- What is the all time high annual SGA for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly SGA year-on-year change?
- What is Cadrenal Therapeutics TTM SGA?
- What is the all time high TTM SGA for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics TTM SGA year-on-year change?
What is Cadrenal Therapeutics annual SGA?
The current annual SGA of CVKD is $3.55 M
What is the all time high annual SGA for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual SGA is $3.55 M
What is Cadrenal Therapeutics quarterly SGA?
The current quarterly SGA of CVKD is $1.67 M
What is the all time high quarterly SGA for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly SGA is $1.67 M
What is Cadrenal Therapeutics quarterly SGA year-on-year change?
Over the past year, CVKD quarterly SGA has changed by $0.00 (0.00%)
What is Cadrenal Therapeutics TTM SGA?
The current TTM SGA of CVKD is -$72.47 M
What is the all time high TTM SGA for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high TTM SGA is -$678.80 K
What is Cadrenal Therapeutics TTM SGA year-on-year change?
Over the past year, CVKD TTM SGA has changed by -$77.38 M (-1574.33%)